Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism.
Cell. 2012 Apr 27; 149(3):656-70
Martin Fernandez-Zapico
19 Jul 2012
|
New Finding, Novel Drug Target
One of the major consequences of tumor progression is a metabolic reprogramming to meet the requirements for continuous tumor proliferation. Although this phenomenon is clearly established, the mechanism regulating this switch remains poorly understood. In this study using an inducible KrasG12D pancreatic cancer model, Ying et al....
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.